June 22  2007 Senators Kennedy  Hatch  Clinton  Enzi Announce FDA Biologics Agreement                                                                                                                                                                                                                                                                                                                                           Washington  DC   Today  Senators Kennedy  Hatch  Clinton  and Enzi announced an agreement on legislation authorizing the FDA to approve a follow on version of biologic therapies  The legislation includes standards for FDA to approve follow on biologics  a mechanism to resolve patents in an expedited way  and strong but responsible incentives to encourage innovation and the development of new therapies  A summary of the legislation will follow    Senator Kennedy said  This century of the life sciences offers unlimited promise of new hope and new help for millions of patients   Congress has a responsibility to encourage the innovation that leads to these new medical miracles  and to see that they are affordable for the patients who need them   The bipartisan legislation we announce today achieves these two important goals  Just as generic drugs have helped bring down the costs of medicines for millions of Americans  new follow on versions of breakthrough biologics will make these innovative treatments more affordable for the patients who need them   Our bipartisan legislation also includes strong and responsible incentives to encourage dynamic new biotechnology companies to invest in the innovations that will produce the cures of tomorrow  Our legislation also includes strong safeguards to ensure patient safety    Senator Hatch said  Its crucial that Congress get this right because biologics are the future of medicine  Its taken a lot of effort  but weve achieved a good balance in this bill  Just as we did with Hatch Waxman in 1984  were giving incentives for both pioneer and generic drug firms  Were ensuring that we continue to get the latest medical breakthroughs while creating a clear pathway to get less expensive biologics on the market quickly    Senator Clinton said  Allowing generic versions of biologic drugs will help fulfill the promise of these cutting edge medicines   By breaking the pharmaceutical industrys monopoly on these medications  we will improve healthcare and reduce costs dramatically for seniors  families and employers  We will stretch precious healthcare dollars further in Medicare and Medicaid  And we will enable more Americans access to affordable treatments that could improve or even save their lives  This is truly a win win for consumers and our country    Senator Enzi said  This legislation captures a delicate balance between access and innovation while maintaining the highest standard of safety   I predict that very shortly  Senators Kennedy  Hatch  Clinton  and I will look back at this legislation with great pride  as it will be seen as a vital part of insuring our aging population has access to innovative  reliable  and safe medicines   Biologics already are making it possible for thousands of Americans to live productive lives and changing the way we treat deadly diseases like cancer and infectious diseases   The agreement weve reached today holds new hope that we can further expand access of these remarkable medicines to more patients who need help combating deadly diseases         